ArticleMetabolomics : Official journal of the Metabolomic Society2025
Dried blood spots capture a wide range of metabolic pathways and biological changes associated with exercise.
Article in Metabolomics : Official journal of the Metabolomic Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Optimization of a targeted metabolomics kit for dried blood spots analysis and longitudinal comparison with serum.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- Metabolic Adaptation during Cardiac Exercise Rehabilitation in Patients after a First Myocardial Infarction.Journal of proteome research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMetabolomics is poised to significantly advance our ability to diagnose and characterize disease, identify diagnostic and prognostic biomarkers, and monitor a patient's response to treatment. Despite these benefits, metabolomics-based diagnostic tests have not been adapted into clinical practice primarily because metabolomics technologies, which include high performance liquid chromatography and mass spectrometry, are not conducive to point-of-care. Expanding the reach of metabolomics-based testing requires centralized technology to be more accessible.
methodsOne way to achieve this is by utilizing dried blood spots (DBS) as a diagnostic testing sample type. Their easy collection, lack of reliance on cold chain, and cost-effective storage and shipment make them the ideal sample type for diagnostic testing that requires a centralized technology. To date, few studies have investigated the ability of DBS to capture the global metabolome and track biological changes in individual subjects.
resultsIn this feasibilty study, we tested these factors by performing untargeted metabolic profiling on DBS collected from study volunteers before and after exercising. We compared our results in DBS to results in serum and plasma that have been reported in the literature.
conclusionsOverall, our findings closely agreed with published studies, showing that DBS may be a viable sample type for metabolomics-based diagnostic and wellness testing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.